You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
業聚醫療(06929.HK)擬收購PT Revass Utama Medika的84%股權
格隆匯 11-27 07:39

格隆匯11月27日丨業聚醫療(06929.HK)發佈公吿,2023年11月27日,買方(OrbusNeich Medical Company Limited,,公司的間接全資附屬公司)與賣方(MZI、AM、BB及IBKP)訂立買賣協議,賣方有條件同意出售佔目標公司84%的已發行股本的銷售股份。購買價不得低於1008萬美元或高於2016萬美元。交割後,目標公司將由買方持有84%權益。目標公司將成為公司的間接非全資附屬公司,且目標公司的財務業績將於集團的財務報表綜合入賬。

目標公司(即PT Revass Utama Medika)為一家於印度尼西亞共和國註冊成立的有限公司。截至本公吿日期,目標公司由MZI持有45%的股權,AM持有28%的股權,BB持有19%的股權,及IBKP持有8%的股權。目標公司主要於印度尼西亞從事心血管介入、神經介入、外周介入及連續腎臟替代療法產品的銷售及分銷。

公吿表示,目標公司在印度尼西亞銷售及分銷心血管介入、神經介入、外周介入及連續腎臟替代療法產品方面擁有良好的聲譽及業務關係。目標公司目前是公司於印度尼西亞的醫療器械獨家分銷商。監於印度尼西亞醫療器械的巨大市場潛力及近期印度尼西亞政府支持醫療器械行業的政策,收購事項將使集團能夠利用目標公司的經驗及專業知識,進一步擴大及發展其於印度尼西亞的直銷團隊銷售能力。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account